Correlation Between Surrozen and Seres Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Surrozen and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and Seres Therapeutics, you can compare the effects of market volatilities on Surrozen and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Seres Therapeutics.

Diversification Opportunities for Surrozen and Seres Therapeutics

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Surrozen and Seres is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Surrozen i.e., Surrozen and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Surrozen and Seres Therapeutics

Given the investment horizon of 90 days Surrozen is expected to generate 23.15 times less return on investment than Seres Therapeutics. In addition to that, Surrozen is 1.09 times more volatile than Seres Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest  70.00  in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of  19.00  from holding Seres Therapeutics or generate 27.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Surrozen  vs.  Seres Therapeutics

 Performance 
       Timeline  
Surrozen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Surrozen may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Seres Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Surrozen and Seres Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Surrozen and Seres Therapeutics

The main advantage of trading using opposite Surrozen and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.
The idea behind Surrozen and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation